Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Starting treatment news

Show

From To
HIV-positive youth are less likely than adults to achieve viral suppression on antiretroviral treatment

While adolescents and young adults are about as likely as older people to be linked to care after being diagnosed with HIV in the United States,

Published
28 August 2015
By
Liz Highleyman
Starting ART reduces TB risk for HIV-positive patients in South Africa

Starting antiretroviral therapy (ART) significantly reduces the risk of tuberculosis (TB) for patients in South Africa, investigators report in the online edition of AIDS. Overall, ART initiation was associated

Published
07 August 2015
By
Michael Carter
WAVES shows elvitegravir regimen beats boosted atazanavir for women with HIV

A study of antiretroviral treatment specifically for women with HIV showed that a single-tablet regimen containing the integrase inhibitor elvitegravir suppressed the virus better than a regimen

Published
06 August 2015
By
Liz Highleyman
Four years with HIV and counting…

Today marks my fourth anniversary, or annHIVersary if you will, of life with HIV. Those four years have really flown past, so what’s changed? What does the future hold?

Published
04 August 2015
From
Beyond Positive
Stribild Superior to Boosted Atazanavir in Treatment-Naive Women

Stribild proved virologically superior to atazanavir/ritonavir plus tenofovir/emtricitabine (TDF/FTC) at 48 weeks in WAVES, an international trial in 575 antiretroviral-naive women. No one in the Stribild arm had emergent resistance upon virologic failure, compared with 3 women in the atazanavir arm.

Published
27 July 2015
From
NATAP
The Day the HIV Treatment Pendulum Stopped Swinging

Normally at scientific conferences, even when study findings are considered to be major, a single researcher stands at a podium for 10 or 15 minutes, takes the audience on a guided PowerPoint tour of charts and graphs, receives a round of applause, and fields a few questions. Then the session moves on to its next topic. The presentation of the START findings was different.

Published
23 July 2015
From
The Body Pro
Same-day start to antiretroviral treatment leads to faster HIV suppression in San Francisco

A programme at San Francisco General Hospital that offers antiretroviral therapy (ART) on the same day as HIV diagnosis led to a high rate of treatment uptake

Published
23 July 2015
By
Liz Highleyman
IAS 2015: While “game-changing,” START trial draws “line in the sand” and sets “time a’ ticking” to stop preventable illnesses and death, calls for action are accompanied by questions of impact of inequities, obstacles

Study also showed that most commonly used measure — CD4 count does not give accurate projection of illness risk.

Published
21 July 2015
From
Science Speaks
START trial provides definitive evidence of the benefits of early HIV treatment

People who start antiretroviral therapy (ART) immediately after HIV diagnosis, while their CD4 cell count is still high, rather than waiting until it falls below 350 cells/mm3

Published
21 July 2015
By
Liz Highleyman
Young woman stays undetectable for twelve years off treatment after early HIV therapy

The 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) heard today of a case where a young woman, who was infected with

Published
21 July 2015
By
Gus Cairns
← First12345...68Next →

Filter by country